Logo

CC

The Chemours Company

CC

The Chemours Company • NYSE
$12.79 ▲ 2.57% (+0.32)
Market Cap $1.92 B
52w High $22.27
52w Low $9.13
Dividend Yield 0.51%
P/E -6
Volume 955.05K
Outstanding Shares 149.88M

Income Statement

Period Revenue Operating Expense Net Income Net Profit Margin Earnings Per Share EBITDA
Q3-2025 $1.495B ▼ $131M ▼ $60M ▲ 4.013% ▲ $0 ▲ $198M ▲
Q2-2025 $1.615B ▲ $206M ▲ $-381M ▼ -23.591% ▼ $-2.54 ▼ $152M ▼
Q1-2025 $1.368B ▼ $158M ▼ $-4M ▲ -0.292% ▲ $-0.027 ▲ $154M
Q4-2024 $1.394B ▼ $198M ▲ $-8M ▲ -0.574% ▲ $-0.053 ▲ $154M ▲
Q3-2024 $1.501B $164M $-27M -1.799% $-0.18 $117M

Balance Statement

Period Cash & Short-term Total Assets Total Liabilities Total Equity
Q3-2025 $613M ▲ $7.57B ▲ $7.27B ▲ $298M ▲
Q2-2025 $502M ▲ $7.488B ▲ $7.249B ▲ $237M ▼
Q1-2025 $464M ▼ $7.394B ▼ $6.814B ▼ $579M ▼
Q4-2024 $713M ▲ $7.515B ▲ $6.91B ▲ $604M ▼
Q3-2024 $596M $7.463B $6.804B $657M

Cash Flow Statement

Period Net Income Cash From Operations Cash From Investing Cash From Financing Net Change Free Cash Flow
Q3-2025 $60M ▲ $146M ▲ $-35M ▲ $-5M ▲ $112M ▲ $105M ▲
Q2-2025 $-380M ▼ $93M ▲ $-42M ▲ $-27M ▲ $39M ▲ $50M ▲
Q1-2025 $-4M ▲ $-112M ▼ $-86M ▲ $-57M ▼ $-249M ▼ $-196M ▼
Q4-2024 $-8M ▲ $138M ▼ $-107M ▼ $85M ▲ $97M ▲ $29M ▼
Q3-2024 $-19M $139M $-75M $-27M $47M $63M

Revenue by Products

Product Q4-2024Q1-2025Q2-2025Q3-2025
Advanced Performance Materials
Advanced Performance Materials
 $340.00M ▲$290.00M ▼$350.00M ▲$310.00M ▼
Thermal And Specialized Solutions
Thermal And Specialized Solutions
 $410.00M ▲$470.00M ▲$600.00M ▲$560.00M ▼
Titanium Technologies
Titanium Technologies
 $630.00M ▲$600.00M ▼$660.00M ▲$610.00M ▼

Five-Year Company Overview

Income Statement

Income Statement Revenue has grown over the past five years but has softened from its peak, showing the cyclical nature of Chemours’ end markets, especially pigments and industrial chemicals. Profitability has been quite volatile: strong earnings in the middle of the period, a loss in 2023, and only slim profits most recently. Margins have compressed versus earlier years, suggesting pressure from weaker demand, pricing, or higher costs. Overall, the income statement shows a business with strong franchises but exposed to cycles, one‑off charges, and swings in profitability rather than smooth, steady growth.

Balance Sheet

Balance Sheet The balance sheet is asset‑heavy and relatively stable in size, reflecting large plants and long‑lived facilities. Cash levels have come down from earlier years, reducing the cushion. Debt remains sizeable and high relative to the company’s equity, which is quite thin. This points to meaningful financial leverage: the company can benefit more from good years but is also more exposed in downturns or if cash generation weakens. There is no obvious balance sheet collapse, but the capital structure leans aggressive rather than conservative.

Cash Flow

Cash Flow Historically, Chemours generated solid operating cash flow and free cash flow, even after funding its capital spending. In the most recent year, however, cash generation turned negative, which is a notable shift. This likely reflects weaker earnings plus working capital and possibly legal or restructuring cash uses. Capital spending has been steady and moderate, suggesting the company is maintaining, not overspending on, its asset base. The cash flow profile overall is “lumpy”: good underlying cash‑generation capability, but with meaningful vulnerability when earnings or working capital move against it.

Competitive Edge

Competitive Edge Chemours holds strong positions in specialized niches rather than broad commodity chemicals. Iconic brands like Teflon, Ti‑Pure, Opteon, Viton, and Nafion give it recognition and a reputation for performance and reliability. Its scale, global manufacturing footprint, and deep know‑how in fluorine and titanium chemistry create real barriers to entry. The company is tightly integrated with key customers and applications, which makes switching away from Chemours more difficult. At the same time, it faces capable global rivals, regulatory scrutiny (especially around environmental and climate topics), and demand cycles in coatings, autos, and electronics, so its moat is meaningful but not risk‑free.

Innovation and R&D

Innovation and R&D Innovation is a clear focus and a major strength. The Discovery Hub and global R&D network support new uses for fluoropolymers, membranes, and refrigerants. Chemours is pushing into higher‑growth, technology‑driven areas such as hydrogen electrolysis (Nafion membranes), semiconductor materials, and advanced cooling fluids for data centers. Its sustainability framework steers R&D toward lower‑emission, more circular products, which aligns with tightening regulations and customer preferences. The pipeline in data‑center immersion cooling, green hydrogen, and next‑generation TiO₂ and refrigerants suggests potential for higher‑value growth, provided the company executes well and regulations remain favorable.

Summary

Chemours combines strong specialty chemical franchises and well‑known brands with a cyclical, leveraged financial profile. The business has shown it can earn healthy profits and cash in good conditions, but recent years highlight how quickly earnings and cash flow can swing when markets weaken or one‑off costs arise. The balance sheet carries meaningful debt and a relatively small equity base, which heightens sensitivity to downturns. On the positive side, Chemours has real competitive advantages in fluoropolymers, TiO₂, and refrigerants, backed by deep technical expertise and tight customer integration. Its innovation efforts in hydrogen, data‑center cooling, and sustainable materials could support longer‑term growth and differentiation. Key uncertainties center on economic cycles, regulatory and environmental pressures, litigation or cleanup costs, and the company’s ability to turn its innovation pipeline into stable, high‑quality earnings and consistent cash flow.

NEWS

November 6, 2025 · 4:30 PM UTC

The Chemours Company Reports Third Quarter 2025 Results

Read more

October 29, 2025 · 5:00 PM UTC

Chemours Announces Fourth Quarter Dividend

Read more

October 16, 2025 · 4:30 PM UTC

Chemours Announces Dates for Third Quarter 2025 Earnings Release and Webcast Conference Call

Read more

September 4, 2025 · 8:45 AM UTC

Core Silver Samples 316 g/t Silver & 0.62% Copper at the Valley Zone as Drilling Continues

Read more

September 3, 2025 · 6:45 AM UTC

Chemours Announces Board Leadership Appointments: Mary Cranston Named Chair, Alister Cowan Named Lead Independent Director

Read more